These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30729449)

  • 21. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.
    van Leeuwen M; Husson O; Alberti P; Arraras JI; Chinot OL; Costantini A; Darlington AS; Dirven L; Eichler M; Hammerlid EB; Holzner B; Johnson CD; Kontogianni M; Kjær TK; Morag O; Nolte S; Nordin A; Pace A; Pinto M; Polz K; Ramage J; Reijneveld JC; Serpentini S; Tomaszewski KA; Vassiliou V; Verdonck-de Leeuw IM; Vistad I; Young TE; Aaronson NK; van de Poll-Franse LV;
    Health Qual Life Outcomes; 2018 Jun; 16(1):114. PubMed ID: 29866185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy.
    Bantema-Joppe EJ; de Bock GH; Woltman-van Iersel M; Busz DM; Ranchor AV; Langendijk JA; Maduro JH; van den Heuvel ER
    Br J Cancer; 2015 Feb; 112(4):636-43. PubMed ID: 25602967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis.
    Zandbergen N; de Rooij BH; Vos MC; Pijnenborg JMA; Boll D; Kruitwagen RFPM; van de Poll-Franse LV; Ezendam NPM
    Acta Oncol; 2019 May; 58(5):790-800. PubMed ID: 30698069
    [No Abstract]   [Full Text] [Related]  

  • 24. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
    Browall M; Ahlberg K; Karlsson P; Danielson E; Persson LO; Gaston-Johansson F
    Eur J Oncol Nurs; 2008 Jul; 12(3):180-9. PubMed ID: 18343197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
    Murgić J; Soldić Z; Vrljić D; Samija I; Kirac I; Bolanca A; Kusić Z
    Coll Antropol; 2012 Dec; 36(4):1335-41. PubMed ID: 23390830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
    Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
    Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
    PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Return to work and psychosocial trajectories after breast cancer: a longitudinal and sequential approach.
    Rubion E; Bourdon M; Sébille V; Blanchin M; Bertin M
    Support Care Cancer; 2024 Apr; 32(5):307. PubMed ID: 38662233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Post-diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea.
    Mai TTX; Choi JH; Lee MK; Chang YJ; Jung SY; Cho H; Lee ES
    Cancer Res Treat; 2019 Oct; 51(4):1600-1611. PubMed ID: 30999723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
    Adam S; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Rohrmann S; Brenner H; Arndt V
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13076. PubMed ID: 31050091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis.
    Schmidt ME; Wiskemann J; Steindorf K
    Qual Life Res; 2018 Aug; 27(8):2077-2086. PubMed ID: 29740782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E.
    Darling GE; Sulman J; Espin-Garcia O; Trudel JG; Atenafu EG; Kidane B
    J Cancer Surviv; 2021 Aug; 15(4):641-650. PubMed ID: 33106994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
    Hong F; Bosco JL; Bush N; Berry DL
    BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.
    Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Pogoda K; Velikova G; Bjelic-Radisic V; Cardoso F; Brain E; Ignatiadis M; Piccart M; Van Tienhoven G; Mansel R; Wildiers H; Bottomley A;
    Eur J Cancer; 2020 Jan; 125():69-82. PubMed ID: 31838407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trajectories of quality of life in breast cancer survivors during the first year after treatment: a longitudinal study.
    Park JH; Jung YS; Kim JY; Bae SH
    BMC Womens Health; 2023 Jan; 23(1):12. PubMed ID: 36627606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    Ratjen I; Schafmayer C; Enderle J; di Giuseppe R; Waniek S; Koch M; Burmeister G; Nöthlings U; Hampe J; Schlesinger S; Lieb W
    BMC Cancer; 2018 Nov; 18(1):1156. PubMed ID: 30466408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
    Habets EJ; Taphoorn MJ; Nederend S; Klein M; Delgadillo D; Hoang-Xuan K; Bottomley A; Allgeier A; Seute T; Gijtenbeek AM; de Gans J; Enting RH; Tijssen CC; van den Bent MJ; Reijneveld JC
    J Neurooncol; 2014 Jan; 116(1):161-8. PubMed ID: 24162809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.